- Growth in operating expenses
- Cash burn
Genomic sequencing group Oxford Nanopore Technologies (ONT) spent much of last year in an in-between space: revenue from two of its major contracts was dwindling as it made greater investments in securing new business. Unsurprisingly, its losses widened as a result.